Thus, routine testing for NLR, CRP, ESR, Troponin-I, BUN, creatinine, AST, ALT, CK-MB, LDH and D-dimer in severe COVID-19 is beneficial in monitoring clinical progression and can predict outcome of the disease. This evidence concerns the gene GPT and COVID-19.